The trades put some of Ark's better-known holdings on the sell side, including AMD, Alphabet, and SpaceX, while its genomics-focused ARK Genomic Revolution ETF continued to add to biotech companies.
During an interview with CNBC, Bernstein’s Madison Rezaei highlighted a potentially unexpected group of winners, which are ...
The U.S. President said in a post on Truth Social that the arrangement would involve multiple waves of Russian diesel ...
Tesla’s week mixed a delivery beat and a Shanghai export surge with a European software rename and a larger Texas Cybercab ...
During an interview with CNBC, Lee argued that the very factors weighing on stocks today, including AI pessimism and high borrowing costs, could eventually fuel a reversal.
Microsoft Corp.(MSFT) announced Friday the launch of a specialized artificial intelligence system designed to execute rapid ...
U.S. stock indices ended higher on Friday as technology stocks recovered from previous session losses and investors prepare ...
Starknet’s (STRK) token rallied on Friday morning, outperforming Bitcoin (BTC) and climbing to a nine-month high in its ...
ASTS CEO Abel Avellan said in a post on X that American operators hold about 1,000 MHz of low- and mid-band spectrum that can ...
Moderna shares on Friday were driven by multiple catalysts, including a Nasdaq-100 entry, a New York Times report on a ...
Approval rests on the late-stage SOLARIS study, where investigators reported better overall symptoms, a clear drop in illness ...
SpaceX (SPCX) could need to build a ground-based mobile network to compete with established U.S. telecom operators following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results